Statistical flags indicate unusual patterns — not proof of fraud or wrongdoing. Read our methodology

Provider 1770669038

NPI: 1770669038Share
Active Billing Period:2019-102024-11(62 months)

Total Paid

$8.0M

$7,989,230

Total Claims

31K

Beneficiaries

1,575

19.8 claims/patient

Avg Cost/Claim

$256

Monthly Spending Trend

Yearly Spending

2019
$318K
+717%
2020
$2.6M
-58%
2021
$1.1M
+17%
2022
$1.3M
+1%
2023
$1.3M
+12%
2024
$1.4M

Procedure Breakdown

Cost per claim compared to national benchmarks

This provider bills for 4 distinct procedure codes. The top code (Q5001 (Injection, filgrastim-sndz, biosimilar, 1 mcg)) accounts for 84% of total spending.

Q5001Top 25%

Injection, filgrastim-sndz, biosimilar, 1 mcg

$6.7M

27K claims · 84.1%

Your Cost: $246.28/claim|Median: $23.43
10.5× median
T2042Normal range

Financial management, self-directed, waiver, per month

$645K

1,880 claims · 8.1%

Your Cost: $343.18/claim|Median: $188.03
1.8× median
T2046Normal range

Habilitation, residential, waiver; per month

$582K

1,987 claims · 7.3%

Your Cost: $292.87/claim|Median: $1,795.74
0.2× median
Q5004Top 25%

$43K

54 claims · 0.5%

Your Cost: $802.17/claim|Median: $127.12
6.3× median